U.S. Life Sciences Stock News

Why Restaurant Brands International Is On Investors’ Radar Today Restaurant Brands International (QSR) is catching attention after recent share price moves, with the stock down about 3% over the past month and roughly 3% over the past 3 months. That pullback comes as the company reports annual revenue of US$9.4b and net income of US$902 million, giving investors fresh numbers to weigh against the current share price of US$66.14. See our latest analysis for Restaurant Brands...

Recent trading in Bio-Rad Laboratories (BIO) has drawn attention after a series of negative returns over the past month and past 3 months, prompting investors to reassess what the current share price may already reflect. See our latest analysis for Bio-Rad Laboratories. With the share price at US$256.56 after a 12.26% one-day and 18.17% 30-day share price decline, recent weakness sits against a longer backdrop of pressured total shareholder returns, including a 46.91% 3-year and 59.72%...

Exelon Corporation recently reported fourth-quarter 2025 results showing sales of US$5,412 million and net income of US$593 million, alongside full-year 2025 sales of US$24.26 billion and net income of US$2.77 billion, and its Board declared a regular quarterly dividend of US$0.42 per share payable in March 2026. These earnings beats, paired with an increased dividend and a US$41.30 billion long-term grid and transmission investment plan, highlight Exelon’s focus on regulated infrastructure...

nVent Electric (NVT) is back in focus after reporting fourth quarter and full year 2025 results that paired sharp year over year growth in sales and earnings with renewed analyst confidence. See our latest analysis for nVent Electric. At a share price of $113.25, nVent Electric has seen an 8.8% 90 day share price return and a very strong 1 year total shareholder return of 67.43%, which points to momentum building around its earnings progress, datacenter exposure and acquisition pipeline, even...

What the latest quarter means for Monolithic Power Systems stock Monolithic Power Systems (MPWR) just posted record quarterly revenue and earnings that came in ahead of analyst expectations, with demand in enterprise data, communications, and automotive driving the story and helping explain the recent share move. See our latest analysis for Monolithic Power Systems. At a share price of US$1,171.47, Monolithic Power Systems has a 30-day share price return of 13.39% and a 90-day share price...

IBM has agreed to acquire Confluent in a definitive deal, bringing the data streaming specialist into its broader enterprise software portfolio. The agreement follows strong quarterly revenue and earnings results from Confluent, which trades under ticker NasdaqGS:CFLT. The transaction marks a major ownership shift for Confluent shareholders at a current share price of $30.56. For investors watching NasdaqGS:CFLT, this deal comes after a mixed share price record, with the stock up 20.5% over...

Invesco (NYSE:IVZ) reported a significant rise in assets under management, supported by strong net long term inflows. Investor demand across the firm’s ETF, active, and private market platforms contributed to the higher preliminary AUM figures. The update highlights broad interest in Invesco’s product set during a period of supportive market conditions. For shareholders, the latest AUM update arrives with Invesco shares trading at $26.52. The stock has returned 49.2% over the past year and...

Rigetti Computing (RGTI) is back in focus after a TD Cowen downgrade, with the firm highlighting more than US$300 million in potential fabrication funding needs, rising competitive pressure, and the company’s absence from DARPA QBI Stage B participation. See our latest analysis for Rigetti Computing. The TD Cowen downgrade comes after a sharp reset in Rigetti’s momentum, with a 37.2% 1 month share price return decline and a 31.8% year to date share price return drop, even though the 3 year...

In February 2026, Saia, Inc. reported fourth-quarter 2025 revenue of US$789.95 million, roughly flat year on year, while net income fell to US$47.52 million and diluted earnings per share from continuing operations declined to US$1.77. Despite recording record quarterly revenue and completing its first full year as a national network, Saia’s profitability weakened as higher self-insurance costs and a softer freight backdrop pushed its operating ratio to 91.9%. Now we’ll explore how Saia’s...

In February 2026, Housecall Pro announced a new native integration with Yelp, allowing high-intent Yelp “Request a Quote” leads to flow directly into Housecall Pro’s Job Inbox alongside leads from Google, Thumbtack and other platforms, while Yelp also reported 2025 net revenue of US$1.46 billion and net income of US$145.60 million and issued 2026 revenue guidance of US$1.46 billion to US$1.48 billion. Despite record 2025 results and expanded AI initiatives, including the Hatch acquisition...

Why N-able (NABL) is on investors’ radar N-able (NABL) has drawn investor attention after recent trading left the stock at US$5.35, with returns over the past month and past 3 months under pressure and the 1 year total return also negative. With annual revenue of US$497.665 million and net income reported as a US$6.511 million loss, the company’s value score of 6 and an indicated intrinsic discount provide a starting point for investors assessing risk and potential reward. See our latest...

If you are trying to figure out whether Madrigal Pharmaceuticals is priced attractively today, you will want to look beyond the share price and consider what different valuation methods are signaling. The stock closed at US$464.71, with a 2.7% decline over 7 days, a 7.4% decline over 30 days, a 21.7% decline year to date, a 37.8% gain over 1 year, a 53.2% gain over 3 years, and a 281.3% gain over 5 years. These figures can influence how investors think about both upside potential and...

Wondering if Klarna Group at US$18.11 is a bargain or a value trap? This article walks you through what the current price might really be telling you. The stock has recently seen sharp moves, with a 7 day return of an 11.7% decline and a 30 day return of a 37.6% decline, and it sits 36.6% below its year to date level. Recent headlines around Klarna Group have kept investor attention on the business model and competitive position, which helps frame these price swings. This article uses that...

Ford Motor (NYSE:F) is in talks with US and European authorities and Chinese automakers, including Geely, about potential joint ventures and technology partnerships. Discussions with Trump administration officials focus on frameworks that could allow Chinese EV makers to operate in the US through joint ventures with American majority control. Parallel talks in Europe involve using Ford’s excess production capacity to build vehicles for Geely and share advanced vehicle technology, including...

Why Tempus AI’s new lung cancer screening partnership matters Tempus AI (TEM) just announced a collaboration with Median Technologies to bring FDA cleared eyonis LCS lung cancer screening software into the Tempus Pixel platform, putting more focus on early detection and clinical workflows. See our latest analysis for Tempus AI. The Median partnership arrives after a choppy stretch for Tempus AI, with a 1 day share price return of 2.30% to US$51.95, following a 30 day share price return...

Crane NXT recently reported past quarterly results showing around 20% year-on-year sales growth in Q4 2025 and 11% for 2025 overall, driven by strong demand in its currency and authentication technology businesses, new wins across 20 currency denominations, and renewed multiyear contracts with major sports leagues. The company is also expanding capacity in its international currency operations and moving to acquire Antares Vision by mid-2026, highlighting how its micro-optics and...

Recent performance snapshot for ServisFirst Bancshares ServisFirst Bancshares (SFBS) has drawn investor attention after a recent share price move, with the stock around $86.14 and showing mixed return patterns across the past year and multi year periods. See our latest analysis for ServisFirst Bancshares. Recent trading has been relatively steady, with a 30 day share price return of 10.07% and a 90 day share price return of 26.27%, while the 1 year total shareholder return of 0.93% decline...

On 12 February 2026, BioLife Solutions, Inc. announced a multi-year agreement to distribute Qkine Limited’s cytokine and growth factor products globally for cell and gene therapy manufacturing, with plans to integrate select products into BioLife’s CellSeal® Connect vial system. This deal broadens BioLife’s reach into the US$500 million cytokines market, which third-party research suggests could reach about US$1.00 billion by 2030, directly linking its biopreservation tools with critical CGT...

If you are wondering whether Flex stock still offers value after a strong run, this article will help you unpack what the current price might be implying about the business. The shares recently closed at US$64.24, with returns of 0.4% over 7 days, a 0.9% decline over 30 days, 0.9% year to date and 51.1% over 1 year. This naturally raises questions about how much of the story is already in the price. Recent news coverage around Flex has focused on its role as a large electronics manufacturing...

Upstart Holdings, Inc. reported fourth‑quarter 2025 revenue of US$296.09 million and net income of US$18.64 million, marking a return to profitability for both the quarter and full year compared with losses in 2024. Alongside these results, Upstart unveiled an extensive leadership reshuffle and issued multi‑year revenue guidance through 2028, signaling a shift in how it balances growth ambitions with execution and governance. We’ll now examine how Upstart’s return to profitability and...

Conference spotlight and access program put Syndax Pharmaceuticals (SNDX) in focus Syndax Pharmaceuticals (SNDX) is back on investors radar after positive Revuforj trial data, a new Managed Access Program with the World Orphan Drug Alliance, and a high profile slot at Guggenheim Securities Emerging Outlook Biotech Summit 2026. See our latest analysis for Syndax Pharmaceuticals. Despite a softer patch recently, with a 1 day share price return of a 3.12% decline and a 7 day share price return...

NeoVolta (NEOV) has just posted its Q2 2026 numbers, with Q1 2026 revenue at US$6.7 million and a net loss of US$1.2 million, translating into basic EPS of a US$0.04 loss. The company has seen quarterly revenue move from US$0.6 million in Q1 2025 through US$1.1 million in Q2 2025, US$2.0 million in Q3 2025 and US$4.8 million in Q4 2025 to US$6.7 million in Q1 2026, while EPS over the same stretch ranged from a loss of US$0.03 to a loss of US$0.05 per share. For investors, the latest set of...

Why EPAM Systems (EPAM) Is Back on Investors’ Radar Fresh attention on EPAM Systems (EPAM) follows research highlighting its stronger earnings outlook and value metrics versus Infosys, positioning the US software services group as a comparatively attractive IT services option. See our latest analysis for EPAM Systems. At a share price of US$166.37, EPAM has seen a sharp 21.75% 1 month share price decline and a 37.48% 1 year total shareholder return decline. This suggests recent earnings and...

If you are wondering whether Oracle's share price still reflects good value or is already pricing in a lot of optimism, this article will walk through what the current market price might be implying. Oracle recently closed at US$160.14, with returns of 12.1% over the past week, a 16.2% decline over the past month, an 18.2% decline year to date, a 7.1% decline over the past year, 90.2% over three years and 180.5% over five years. Together, these figures give a mixed picture for anyone trying...